Trident Lifeline Ltd. (TLL) Share Price Rises 8.71% Today on Rs 361.7 Cr Market Cap
- September 16, 2026
- Posted by: Harsh Piplani
- Category: News
TLL Share Price moved higher today as Trident Lifeline Ltd. advanced 8.71% to Rs 308.8 from the previous close of Rs 284.05. The day move of Rs 24.75 was matched by a session high of Rs 308.8 and a low of Rs 294.4, while turnover stood at Rs 0.61 crore and market capitalisation at Rs 361.7 crore. This TLL Share Price Today update confirms a clear same-day price rise, but the supplied data does not establish a company-specific catalyst. For readers tracking TLL Stock News, the event is relevant because it combines a sharp share price gain with a valuation profile that can be compared with the broader Healthcare and Pharmaceuticals & Drugs universe on Univest.
In Stock Market Today terms, TLL has entered the day’s Stocks in News list as one of the notable Stocks Rising Today on price action alone. Univest is highlighting the move factually, without adding an unverified reason, so investors can focus on the numbers first: price, market capitalisation, turnover and relative valuation.
TLL Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 308.8 |
| Previous Close | Rs 284.05 |
| Today's Move | Rs 24.75 (+8.71%) |
| Open | Rs 295 |
| High | Rs 308.8 |
| Low | Rs 294.4 |
| Turnover | Rs 0.61 crore |
| Market Capitalisation | Rs 361.7 crore |
| Market Cap Category | Micro Cap |
Trident Lifeline Ltd. (TLL) rose to Rs 308.8 from the previous close of Rs 284.05, a move of Rs 24.75 or 8.71%. The stock opened at Rs 295, reached a high of Rs 308.8, recorded a low of Rs 294.4.
TLL Share Price opened at Rs 295, moved within a Rs 294.4 to Rs 308.8 range, and finished at the day’s high of Rs 308.8. The stock rose Rs 24.75, or 8.71%, versus the previous close of Rs 284.05. That makes TLL a clear top gainer today on a price basis, even though the supplied data does not identify a specific trigger. The move is best read as a factual share price rise rather than a stated reaction to any disclosed event. Turnover of Rs 0.61 crore provides a traded-value reference for the session, but it should not be used to infer participation or investor behaviour. For TLL Share Price Live tracking on Univest, the key question is simply how the stock behaves after this higher close.
Trident Lifeline Ltd. (TLL) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 361.7 crore |
| P/E Ratio | 17.84x |
| P/B Ratio | 3.45x |
| ROE | 18.78% |
| ROCE | 19.17% |
| EPS | Rs 15.92 |
| Book Value Per Share | Rs 82.4 |
| Dividend Yield | 0% |
Trident Lifeline Ltd. (TLL) fundamental metrics show P/E 17.84x, P/B 3.45x, ROE 18.78%, ROCE 19.17%. These figures provide context only and are not a buy or sell signal.
Trident Lifeline Ltd. has a market capitalisation of Rs 361.7 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 17.84x, P/B at 3.45x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.78% and ROCE of 19.17%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 15.92, book value per share of Rs 82.4, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.74x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 17.84x |
| Benchmark Median P/E | 31.74x |
| Benchmark Average P/E | 47.98x |
| Benchmark P/E Range | 3.29x to 683.37x |
| Company P/B Ratio | 3.45x |
| Benchmark Median P/B | 3.02x |
| Company ROE | 18.78% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 19.17% |
| Benchmark Median ROCE | 13.65% |
| Company Market Capitalisation | Rs 361.7 crore |
| Benchmark Median Market Cap | Rs 750.5 crore |
Trident Lifeline Ltd. (TLL) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Trident Lifeline Ltd. (TLL) has a P/E ratio of 17.84x, which is below the benchmark median of 31.74x, a difference of -43.79%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Trident Lifeline Ltd. (TLL) has a ROE of 18.78%, which is above the benchmark median of 11.78%, a difference of +59.42%. Trident Lifeline Ltd. (TLL) has a ROCE of 19.17%, which is above the benchmark median of 13.65%, a difference of +40.44%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,41,957.5 | 36.4 | 5.09 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,47,576 | 83.41 | 13.81 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,89,233.01 | 84.58 | 20.55 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,11,670.55 | 24.29 | 4.07 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,10,272.68 | 32.62 | 3.13 | 11.83 | 16 |
Trident Lifeline Ltd. (TLL) has a P/E ratio of 17.84x compared with the displayed peer median of 36.4x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.78% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 19.17% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Trident Lifeline Ltd. (TLL) has a market capitalisation of Rs 361.7 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching TLL
- TLL Share Price rose 8.71% today and closed at Rs 308.8 after opening at Rs 295.
- The stock ended at its day high of Rs 308.8, with the day low at Rs 294.4.
- Market capitalisation is Rs 361.7 crore, which is below the same-industry median of Rs 750.5 crore.
- P/E is 17.84 and P/B is 3.45, both useful for TLL Fundamental Analysis on Univest.
- ROE at 18.78% and ROCE at 19.17% sit above the benchmark medians for the same industry.
About Trident Lifeline Ltd.
Trident Lifeline Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Based on the supplied company context, it belongs to a listed pharmaceutical and drugs universe that is typically compared against sector peers through earnings, book value and return metrics on Univest. The available data does not provide segment-wise revenue mix or product categories, so the company description here stays limited to the verified sector and industry classification.
For readers following TLL Company News and TLL Latest News, the most relevant company facts in this event note are its market capitalisation of Rs 361.7 crore, EPS of Rs 15.92, book value of Rs 82.4 and a dividend yield of 0. This makes TLL Share Price a useful entry point for monitoring how the stock is valued relative to the broader Healthcare peer set. Univest keeps the analysis anchored in supplied financial data rather than assumptions.
Track TLL Share Price on Univest
Use Trident Lifeline Ltd. (TLL) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Investors can track TLL Share Price on Univest for live share price updates, fundamental ratios, shareholding pattern, 52-week levels and market insights. Univest also presents TLL Stock Analysis, valuation context, peer comparison and company information in one place so readers can follow TLL Share Price Today with factual reference points.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did TLL Share Price rise today?
Ans. TLL Share Price rose 8.71% to Rs 308.8 today. The supplied data confirms the price move, but it does not establish a company-specific catalyst for the gain. The previous close was Rs 284.05.
What is TLL’s market capitalisation?
Ans. TLL’s market capitalisation is Rs 361.7 crore. In the same-industry benchmark, that sits below the median market cap of Rs 750.5 crore across 200 companies. The company operates in the Healthcare sector.
How does TLL compare on valuation with its industry?
Ans. TLL trades at a P/E of 17.84 and a P/B of 3.45. Its P/E is below the same-industry median of 31.74, while its P/B is slightly above the median of 3.02.
What do TLL’s profitability ratios show?
Ans. TLL reports ROE of 18.78% and ROCE of 19.17%. Both figures are above the same-industry benchmark medians of 11.78% and 13.65%, respectively, in the supplied dataset. ROE stands at 18.78%.
Does TLL pay a dividend?
Ans. The dividend yield is 0, so the supplied data does not show a dividend payout contribution to TLL Share Price. Investors can still review EPS of Rs 15.92 and book value of Rs 82.4.
Where does TLL operate?
Ans. TLL operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. That industry context is important for comparing its valuation, market capitalisation and return ratios with other listed pharmaceutical companies.
